Form 8-K · Current report
Motorola Solutions 8-K, filed Sep 9, 2026
- Filed
- CIK
- 0000068505
- Accession no.
- 0001193125-26-386490
Summary
Motorola Solutions' board of directors authorized a $2 billion increase to the company's share repurchase program, raising the total authorization since July 2011 to $20 billion with no expiration date. About $0.6 billion of authority remained under the prior $18 billion program at the end of the second quarter of 2026, and the company had repurchased roughly $17.4 billion of common stock under the program through July 4, 2026.
Key points
- The repurchase program's total authorization since July 2011 rises to $20 billion, with no expiration date.
- Approximately $0.6 billion in repurchase authority remained under the previously authorized $18 billion program at the end of the second quarter of 2026.
- Through July 4, 2026, the company repurchased approximately $17.4 billion of common stock under the existing program.
- Repurchases may be made in the open market or in privately negotiated transactions, subject to market conditions.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On September 9, 2026, Motorola Solutions, Inc. (the “Company”) issued a press release announcing that its Board of Directors has authorized an increase in its share repurchase program to permit the Company to purchase up to an additional $2.0 billion of its outstanding common shares, bringing the total share repurchase program up to $20 billion, with no expiration date for the program. Through July 4, 2026, the Company repurchased approximately $17.4 billion shares of common stock under the existing share repurchase program. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.